Please login to the form below

Not currently logged in
Email:
Password:

New PR hires at Pfizer and Cephalon

Pfizer has hired former GE executive Peter O'Toole as VP, communications in its Washington, DC office, while Cephalon has hired Pfizer's Natalie de Vane as senior director, corporate communications and public affairs

Pfizer has hired former General Electric (GE) executive Peter O'Toole to serve as vice president, communications in its Washington, DC office, while Cephalon has brought Pfizer's Natalie de Vane on board in the position of senior director, corporate communications and public affairs.

O'Toole was previously director, executive communications at GE, a position that he held for about 16 months. Before being promoted to that post, he served as GE's director, public relations, public affairs for nearly five years. He has also worked on the agency side, spending more than four years at Burson-Marstellar, and was a speechwriter to the Secretary of Energy and Special Projects Officer at the US Department of Energy.

O'Toole's post at Pfizer is a newly created position that gives him responsibility for policy, external affairs, and communications.

De Vane recently joined Cephalon from Pfizer, where she was vice president, corporate affairs at Wyeth Nutrition, which became part of Pfizer through the 2009 merger with Wyeth. She was promoted to that post about two years ago, after working in corporate communications for Wyeth for 12 years.

At Cephalon, de Vane's responsibilities include external and internal communications, media relations and corporate brand management. She reports to Fritz Bittenbender, the company's VP of public affairs.

14th January 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics